Author

Elena Oropeza

California State University, San MarcosORCID 0009-0009-2359-3949Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

Matthew Neil BainbridgeiD· 3 shared Svasti HaricharaniD· 3 shared Aloran Mazumder· 2 shared Daniel LozanoiD· 2 shared Jerry Tyler DeWittiD· 2 shared Megha RaghunathaniD· 2 shared Nindo B. PunturiiD· 2 shared Shreya A. RaghavaniD· 2 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Matthew Neil BainbridgeORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedOct 26, 2026

The impact of patient biology on racial disparities in breast cancer outcome

Jerry Tyler DeWitt, D Jimenez-Tovar, Elena Oropeza…·Svasti Haricharan

This study identifies molecular differences in HR+ breast cancer between Black and White women, linking structural factors like poverty to tumor biology and immune signatures.

DOI 10.1158/0008-5472.can-25-5500

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedDec 10, 2025

Aberrant cytoplasmic localization of MLH1 characterizes a sub-clonal breast cancer cell population that seeds recurrence

Aloran Mazumder, Jerry Tyler DeWitt, Elena Oropeza…·Svasti Haricharan

This study identifies aberrant cytoplasmic MLH1 localization in sub-clonal breast cancer cells as a driver of endocrine resistance, showing it predicts response to CDK4/6 inhibitors.

1 citation

humanproteomics

𝕏 PostBluesky

Cancer BiologyScience AdvancesPeer-reviewedJun 30, 2023

Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness

Elena Oropeza, Sinem Şeker, Sabrina Carrel…·Svasti Haricharan

This study identifies how specific cell cycle checkpoint kinase dysregulations influence cancer subtype, metastasis, and treatment response in breast cancer.

15 citations

humanbulk RNA-seq

𝕏 PostBluesky